Inflammatory demyelinating diseases comprise a spectrum of disorders affecting the myelin of the central and peripheral nervous system. These diseases can usually be differentiated on the basis of clinical, radiological, laboratory and pathological findings. Recent studies have contributed to current awareness that inflammatory demyelinating diseases are not restricted to the adult age group, but are more common in pediatric age than previously believed. Some of pediatric inflammatory demyelinating diseases carry an unfavorable long-term prognosis but appropriate treatments can improve the outcome. The possibility of physical and cognitive disability resulting from these diseases, highlights the urgent need for therapeutic strategies for neurorehabilitation, neuroregeneration, and neurorepair. This review discusses characteristics of primary demyelinating diseases more frequently observed in childhood, focusing on epidemiology, clinical aspects and treatments.
Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood. An Update / Properzi, Enrico; Parisi, Pasquale; Papetti, Laura; Nicita, Francesco; Ursitti, Fabiana; DEL BALZO, Francesca; Verrotti, Alberto; Ruggieri, Martino; Iannetti, Paola. - In: CURRENT NEUROPHARMACOLOGY. - ISSN 1570-159X. - STAMPA. - 8:2(2010), pp. 135-148. [10.2174/157015910791233141]
Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood. An Update
Enrico Properzi;Pasquale ParisiSecondo
Writing – Original Draft Preparation
;Laura Papetti;Francesco Nicita;Fabiana Ursitti;Francesca Del Balzo;Paola Iannetti
2010
Abstract
Inflammatory demyelinating diseases comprise a spectrum of disorders affecting the myelin of the central and peripheral nervous system. These diseases can usually be differentiated on the basis of clinical, radiological, laboratory and pathological findings. Recent studies have contributed to current awareness that inflammatory demyelinating diseases are not restricted to the adult age group, but are more common in pediatric age than previously believed. Some of pediatric inflammatory demyelinating diseases carry an unfavorable long-term prognosis but appropriate treatments can improve the outcome. The possibility of physical and cognitive disability resulting from these diseases, highlights the urgent need for therapeutic strategies for neurorehabilitation, neuroregeneration, and neurorepair. This review discusses characteristics of primary demyelinating diseases more frequently observed in childhood, focusing on epidemiology, clinical aspects and treatments.File | Dimensione | Formato | |
---|---|---|---|
Spalice_Clinical-and-Pharmacological_2010.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
322.22 kB
Formato
Adobe PDF
|
322.22 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.